MNMD Definium Therapeutics, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $0 and sold $7.00M on the open market.
Recent MNMD insider trades
- Sep 25, 2026: Roberts Brandi sold 3,377 shares ($123K)
- Sep 25, 2026: Sullivan Mark sold 14,051 shares ($514K)
- Sep 25, 2026: Wiley Matthew T. sold 3,097 shares ($113K)
- Sep 25, 2026: Barrow Robert sold 31,550 shares ($1.15M)
5%+ owners
- BlackRock, Inc.: 8.3% (Schedule 13G/A, filed Feb 5, 2025)
- DRIEHAUS CAPITAL MANAGEMENT LLC: 5.4% (Schedule 13G/A, filed Aug 14, 2026)
- Avoro Capital Advisors LLC: 5.1% (Schedule 13G, filed Feb 17, 2026)